Cost analysis of radiofrequency catheter ablation for atrial fibrillation

Gorenek B., Kudaiberdieva G.

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.167, sa.6, ss.2462-2467, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 167 Sayı: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.ijcard.2013.01.028
  • Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2462-2467
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Atrial fibrillation is the most common arrhythmia associated with increased mortality and morbidity. Its management requires high healthcare expenditures; 52%-70% of expenses for AF care are constituted by hospitalization costs. The current management strategies of pharmacological rhythm control and pharmacological or invasive rate control show no difference in impact on major outcomes in patients with AF. Radiofrequency catheter ablation (RFA) has been shown to reduce the risk of AF recurrence, improve quality of life and reduce hospitalization rate as compared to pharmacological rhythm control and rate control strategies. This review summarizes current knowledge on cost and cost-effectiveness analysis of RFA for patients with atrial fibrillation. (C) 2013 Elsevier Ireland Ltd. All rights reserved.